Additional testing showed that lowering ANGPTL4 levels also led to decreased triglyceride and increased high-density lipoprotein (HDL) levels, both of which are beneficial for reducing CAD risk [90,92]. The gene discussed is ANGPTL4; the disease is coronary artery disorder.